Home > Products > CD28 & CD44
> Recombinant Anti-CD28 x Anti-CD44 Bispecific Antibody (Triple Body)
Recombinant Anti-CD28 x Anti-CD44 Bispecific Antibody (Triple Body) (CAT#: TRIB-057)
Recombinant Anti-CD28 x Anti-CD44 Bispecific Antibody (Triple Body) is designed to be expressed as two polypeptide chains respectively. The Fd fragment and LC from an anti-CD28 antibody are both extended with the scFv fragment from an anti-CD44 antibody. This BsAb can retarget T cells to tumor cells. It is designed for the research of Glioblastoma; Squamous cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD28 x Anti-CD44 Bispecific Antibody (Triple Body) (TRIB-057). Click the button below to contact us or submit your feedback about this product.